Evidence map›Paper›PMID 24495909›Full record

ArticleThe Journal of infectious diseases2014

Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.

Raquel G Cao, Nicolas M Suarez, Gerlinde Obermoser, Santiago M C Lopez, Emilio Flano, Sara E Mertz, Randy A Albrecht, Adolfo García-Sastre, Asuncion Mejias, Hui Xu and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Raquel G CaoCenter for Vaccines and Immunity, The Research Institute.
Nicolas M SuarezCenter for Vaccines and Immunity, The Research Institute.
Gerlinde ObermoserBaylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas.
Santiago M C LopezCenter for Vaccines and Immunity, The Research Institute.
Emilio FlanoCenter for Vaccines and Immunity, The Research Institute.
Sara E MertzCenter for Vaccines and Immunity, The Research Institute.
Randy A AlbrechtDepartment of Microbiology Global Health and Emerging Pathogens Institute.
Adolfo García-SastreDepartment of Microbiology Global Health and Emerging Pathogens Institute Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York.
Asuncion MejiasCenter for Vaccines and Immunity, The Research Institute Department of Pediatrics, Division of Infectious Diseases, Nationwide Children's Hospital The Ohio State University College of Medicine, Columbus, Ohio.
Hui XuBaylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas.
Huanying QinBaylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas.
Derek BlankenshipBaylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas.
Karolina PaluckaBaylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas.
Virginia PascualBaylor Institute for Immunology Research, Baylor Research Institute, Dallas, Texas.
Octavio RamiloCenter for Vaccines and Immunity, The Research Institute Department of Pediatrics, Division of Infectious Diseases, Nationwide Children's Hospital The Ohio State University College of Medicine, Columbus, Ohio.
Baylor University · USImmunité et Cancer · FRThe Ohio State University · USIcahn School of Medicine at Mount Sinai · US

Funding

Vaccine Induced Activation of T Follicular Helper Cell SubsetsU19AI089987 · NIAID · BAYLOR RESEARCH INSTITUTE · PI PASCUAL, MARIA VIRGINIA · 2010 to 2015
$17.0M
NIAID NIH HHS U19 AI089987
6 · The paper itself

Abstract

backgroundLive attenuated influenza vaccine (LAIV) and trivalent inactivated influenza vaccine (TIV) are effective for prevention of influenza virus infection in children, but the mechanisms associated with protection are not well defined.

methodsWe analyzed the differences in B-cell responses and transcriptional profiles in children aged 6 months to 14 years immunized with these 2 vaccines.

resultsLAIV elicited a significant increase in naive, memory, and transitional B cells on day 30 after vaccination, whereas TIV elicited an increased number of plasmablasts on day 7. Antibody titers against the 3 vaccine strains (H1N1, H3N2, and B) were significantly higher in the TIV group and correlated with number of antibody-secreting cells. Both vaccines induced overexpression of interferon (IFN)-signaling genes but with different kinetics. TIV induced expression of IFN genes on day 1 after vaccination in all age groups, and LAIV induced expression of IFN genes on day 7 after vaccination but only in children <5 years old. IFN-related genes overexpressed in both vaccinated groups correlated with H3N2 antibody titers.

conclusionsThese results suggest that LAIV and TIV induced significantly different B-cell responses in vaccinated children. Early induction of IFN appears to be important for development of antibody responses.

Indexed as

Signal TransductionAdolescentAntibodies, NeutralizingAntibodies, ViralAntibody FormationB-LymphocytesChildChild, PreschoolCohort StudiesFemaleGene Expression ProfilingHemagglutination Inhibition TestsHumansInfantInfluenza, HumanInfluenza VaccinesAntibodies, NeutralizingAntibodies, ViralInfluenza VaccinesInterferonsVaccines, AttenuatedVaccines, InactivatedchildrenHI antibodiesInfluenza vaccineinterferonLAIVneutralizing antibodiesTIV

Identifiers

PMID24495909
PMCPMC4092249
OpenAlexW2134231495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.